Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment | NCT01205815 | Trialant
RecruitingObservationalUpdated Sep 19, 2025
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
ClinicalTrials.gov ID
NCT01205815
Lead Sponsor
Vanderbilt-Ingram Cancer CenterOTHER
Overall Status
Recruiting
Study Type
Observational
Enrollment
3,000Estimated
Last Update Posted
Sep 19, 2025Actual
Start Date
Jun 3, 2010Actual
Primary Completion Date
Jun 2027Estimated
Completion Date
Jun 2027Estimated
Brief Summary
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Melanoma
Tissue and blood collection
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria
Pathologically-proven diagnosis of melanoma.
Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.
Exclusion criteria
Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
Any patient unable or unwilling to provide consent.
Observational Model
Other
Time Perspective
Prospective
Vanderbilt-Ingram Service for Timely AccessContact
800-811-8480
Vanderbitl-Ingram Cancer CenterRecruiting
Nashville, Tennessee, United States
Vanderbilt-Ingram Service for Timely AccessContact